Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
243,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
122 °P sammeln
  • Broschiertes Buch

This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
STEFANO FANTI Professor-Department of Experimental, Diagnostic and Specialty Medicine - DIMES Research interests are mainly focused on the use of PET in oncology, with particular reference to innovative radiopharmaceuticals. Engaged in national and international research projects, he collaborates with numerous institutions, including IAEA, EANM GOPINATH GNANASEGARAN Consultant Physician in Nuclear Medicine at Royal Free London NHS Foundation Trust Hospital NHS Foundation Trust. His specialist interests are hybrid imaging and radionuclide therapy. Former Chair of the British Nuclear Medicine Society Education Committee. IGNASI CARRIO Professor of Radiology and Nuclear Medicine at Autonomous University of Barcelona, and Director of the Department of Nuclear Medicine at Hospital Sant Pau in Barcelona, Spain. Main research and scientific activity in Nuclear Medicine and Molecular Imaging, in particular in the fields of Cardiovascular Medicine and Oncology. FormerEditor-in-Chief of the European Journal of Nuclear Medicine and Molecular Imaging. Former President of the European Association of Nuclear Medicine.